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Introduction
The primary aim of controlled ovarian hyperstimulation
(COH) in in vitro fertilization-embryo transfer (IVF-ET)
cycles is to produce a large cohort of mature oocytes
for IVF. Elevated secretion of ovarian steroid hormones
is inevitably associated with COH. Serum estradiol (E2)
levels can be increased more than 10-fold over those
found during spontaneous cycles [1,2]. Because cyclic
changes in the endometrium are regulated by ovarian
steroid hormones, the increased ovarian steroid hormone
secretion from COH may compromise endometrial
receptivity for embryo implantation [3,4].
The effect of such supraphysiologic E2 levels on the
outcome of IVF-ET has been the subject of intense
debate with conflicting evidence [5,6]. Some investiga-
tors have shown that supraphysiologic E2 levels have a
detrimental influence on endometrial receptivity and
IVF outcome [7–17]. However, others did not find high
E2 levels to be detrimental to IVF outcome [18–25].
Adverse effects of a supraphysiologic E2 may include
alterations in both endometrial receptivity and oocyte/
embryo quality.
The purpose of this study was to examine the effects
of high serum E2 levels on the day of human chorionic
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gonadotropin (HCG) administration on pregnancy
achievement in fresh IVF-ET cycles, in which GnRH
analog was used for downregulation.
Materials and Methods
We performed a retrospective analysis of patient char-
acteristics, measures of ovarian response, and rates of
implantation and pregnancy for first cycles only of 
all patients < 35 years of age who underwent IVF-ET.
Between January 1998 and December 2002, 274 IVF
cycles were studied. These patients were divided into
five groups according to their peak E2 levels on the HCG
day: ≤ 2,000 pg/mL (130 cycles); 2,001–3,000 pg/mL
(53 cycles); 3,001–4,000 pg/mL (46 cycles); 4,001–
5,000 pg/mL (29 cycles); > 5,000 pg/mL (16 cycles).
We also compared the outcome of IVF for high respon-
ders (> 15 retrieved oocytes) and normal responders
(≤ 15 retrieved oocytes) defined by Simon et al [13].
All patients underwent ovarian downregulation using
leuprolide acetate. Once downregulation was confirmed,
leuprolide acetate was decreased and gonadotropin
(follicle stimulating hormone or human menopausal
gonadotropin) was started at a dose of three to four
ampoules per day. The ovarian response was assessed
by ultrasound and serum E2 level on the 5th day of
gonadotropin, and serially thereafter. HCG (10,000 IU)
was administered intramuscularly when lead follicles
reached 18 mm in diameter. A serum E2 (peak E2)
level was obtained on the day of HCG administration.
Ultrasound-guided transvaginal oocyte retrieval was
performed 34–36 hours later under intravenous con-
scious sedation. Oocytes were inseminated by using
standard protocols or intracytoplasmic sperm injection
as indicated. Embryos were transferred 72 hours after
follicular aspiration. Patients undergoing IVF-ET received
intramuscular progesterone in oil (50 mg/day) for
luteal support starting on the day of oocyte retrieval.
Pregnancies were documented by measuring serum
hCG 14 days after embryo transfer.
Statistical analyses were performed using SPSS
(SPSS Inc., Chicago, IL, USA). Statistical differences
between groups were determined by analysis of variance
(ANOVA), t test, and χ2 test. All data were expressed
as mean ± standard error of the mean. A p value
< 0.05 was considered significant.
Results
Table 1 compares the IVF outcome of normal respon-
der (≤ 15 oocytes) with high responder (> 15 oocytes)
patients. As expected, there was a significant increase in
the E2 levels (p < 0.001) on the day of HCG injection
in the high responder group. Although the high respon-
der patients were significantly younger (30.2 ± 3.6 years
vs. 33.6 ± 4.1 years) and the number of embryos trans-
ferred was increased (4.2 ± 1.5 vs. 3.8 ± 1.3), pregnancy
and implantation rates were similar between two groups.
Table 2 summarizes the ovarian responses, fertiliza-
tion, and cleavage rates in different groups according
to the serum E2 levels on the day of HCG administra-
tion. The mean number of oocytes obtained in these
five groups was 6.9, 11.5, 16.2, 21.4, and 27.3, respec-
tively, and a statistically significant difference was found
among all five groups (p < 0.001, ANOVA). The fertiliza-
tion and cleavage rates were similar for the five groups.
No differences were found among the five groups with
regard to the number of embryos replaced. Although
at peak serum E2 greater than 5,000 pg/mL, the preg-
nancy rate dropped to 25.0% and the implantation
Table 1. In vitro fertilization outcome in high responders (> 15 retrieved oocytes) and normal responders (≤ 15 retrieved 
oocytes)*
Retrieved oocytes, n
≤ 15 > 15
p
Cycles, n 185 89
Age (yr)* 33.6 ± 4.1 30.2 ± 3.6 < 0.05
Peak E2 level (pg/mL)* 1,714 ± 875 3,947 ± 1,093 < 0.001
Oocytes, n* 8.3 ± 3.5 21.8 ± 5.7 < 0.001
Fertilization rate (%)* 70.2 ± 14.7 69.8 ± 13.2 NS
Embryos transferred, n* 3.8 ± 1.3 4.2 ± 1.5 NS
Pregnancy rate, n (%) 63/185 (34.1) 29/89 (32.6) NS
Implantation rate, n (%) 82/703 (11.7) 41/365 (11.2) NS
*Data are presented as mean ± standard deviation. NS = not significant.
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rate also dropped to 8.6%, there were no statistically
significant differences among these five groups about
the pregnancy and implantation rates (Figure).
Discussion
Since the advent of assisted reproduction, investigators
have sought to elucidate factors that may limit suc-
cessful embryo implantation in IVF-ET cycles. Embryo
quality and endometrial receptivity were identified as
important determinants of reproductive outcome in
assisted reproduction. Successful implantation depends
on the synchronized development of both embryos
and endometrium. The general assumption is that the
natural ovulatory cycle produces the ideal hormonal
level for gametogenesis and endometrial receptivity
[26]. Deviations from normal values observed in the
menstrual cycle are believed to be detrimental to the
quality of the developing endometrium. Specifically,
excessively high E2 levels observed with ovarian stimu-
lation are thought to adversely effect embryo quality
and/or endometrial receptivity.
Simon et al [13] defined high responders as women
who had > 15 retrieved oocytes. Fifty-nine high respon-
ders and 105 normal responders (≤ 15 oocytes) were
evaluated. The fertilization rates were not different,
but the pregnancy and implantation rates were markedly
decreased when peak E2 levels exceeded 2,500 pg/mL,
regardless of the number of retrieved oocytes [13]. 
Table 2. Ovarian responses and fertilization rates by peak E2 levels*
Peak E2 levels (pg/mL)
≤ 2,000 2,001–3,000 3,001–4,000 4,001–5,000 > 5,000
Cycles, n 130 53 46 29 16
Age (yr) 32.9 ± 4.1 33.1 ± 4.3 32.3 ± 3.5 31.4 ± 3.9 30.1 ± 3.6
Oocytes retrieved, n 6.9 ± 3.1 11.5 ± 3.0 16.2 ± 3.4 21.4 ± 5.2 27.3 ± 10.0
Fertilization rate (%)† 70.3 ± 18.6 69.8 ± 20.1 70.7 ± 15.9 71.1 ± 21.1 69.7 ± 15.6
Cleavage rate (%)† 89.4 ± 21.3 91.0 ± 23.5 90.3 ± 19.8 90.7 ± 27.8 91.1 ± 25.0
Embryos transferred, n† 3.8 ± 1.1 4.1 ± 0.9 4.0 ± 1.2 3.9 ± 1.3 4.4 ± 1.1
Pregnancy rate, n (%)† 46/130 (35.4) 21/53 (39.6) 14/46 (30.4) 9/29 (31.0) 4/16 (25.0)
Implantation rate, n (%)† 63/491 (12.8) 26/214 (12.1) 19/184 (10.3) 12/109 (11.0) 6/70 (8.6)
*Data are presented as mean ± standard deviation; †there were no statistically significant differences between the different groups.
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Figure. Pregnancy rates and implantation rates in groups with different E2 levels.
The results of the current study did not show any differ-
ence in implantation and pregnancy rates between cycles
with ≤ 15 oocytes and with > 15 oocytes obtained
(Table 1). Similar findings were also demonstrated
previously by Ng et al [17] in 1,122 women undergoing
IVF treatment. This reinforced the concept of a direct
adverse effect of higher E2 levels (rather than the number
of oocytes retrieved) on endometrial receptivity.
The detrimental effects of very high E2 levels on
implantation may result from poor embryo quality, lower
endometrial receptivity, or a combination of both. In
accordance with a previous report [27], the present study
found that the oocyte fertilization and embryo cleavage
rates did not vary among these five groups (Table 2).
Moreover, Ng et al [17] showed similar implantation and
pregnancy rates in subsequent frozen–thawed embryo
transfer cycles in those who did not become pregnant
in the fresh IVF cycles with high E2 level. These clinical
data indicated that oocyte and embryo quality were
not affected by the high E2 level [17,27,28].
However, a decrease in pregnancy and implantation
rates was observed when E2 levels were > 5,000 pg/mL
compared with those having lower E2 levels from our
study (Figure). Although no statistically significant dif-
ferences were detected about the pregnancy and implan-
tation rates among the five groups, it may be due to
the small sample size (n = 16) in the very high E2 levels
(> 5,000 pg/mL) group. Different mechanisms have
been suggested to explain the adverse effect of exces-
sively high E2 levels and are mainly focused on possible
deleterious effects on the endometrium [29]. Valbuena
et al [30] have suggested that high E2 levels are detri-
mental to endometrial receptivity and have suggested
a step-down regimen to increase endometrial receptivity
in high responders [16]. Although the exact mecha-
nisms have not yet been determined, reduced implan-
tation in high E2 levels might be related to asynchronous
endometrial development with delayed glandular mat-
uration and advanced stromal morphology [31,32],
suboptimal endometrial perfusion [33–35], and aber-
rant uterine expression of implantation-related genes
[36]. Ma et al [36] found that the window of uterine
receptivity remains open for an extended period at
lower estrogen levels but rapidly closes at higher levels.
The uterine refractoriness that follows the receptive
state at high estrogen levels is accompanied by aber-
rant uterine expression of implantation-related genes
(COX-2 and LIF). In a recent study, Makkar et al [37]
demonstrated that a high serum E2 level had a negative
effect on endometrial interleukin-11 and interleukin-6
expression. Reduced interleukin-11 and interleukin-6
expression in the peri-implantation endometrium may
account for the lower implantation and pregnancy rates
in the excessive responders compared with those in
natural cycles and moderate responders. In addition,
there are possible adverse effects directly on the embryo
that could reduce the chance for blastocyst adhesion
and implantation [38].
Ng et al [17] showed that a reduction in implanta-
tion and pregnancy rates in cycles with serum E2 levels
≥ 5,000 pg/mL implied that fresh embryos arising from
these stimulated cycles should be cryopreserved for trans-
fer later. The resulting pregnancy rates in frozen–thawed
embryo transfer cycles would not be compromised and
the risk of moderate or severe ovarian hyperstimulation
syndrome (OHSS) could be further reduced [17].
A recent study [39] showed high pregnancy rates
and successful prevention of severe OHSS by “coast-
ing” of hyper-responder patients in IVF. Serum E2 
levels were markedly reduced from the 1st day of with-
holding gonadotropin to the day of HCG administra-
tion. These data suggest that the high E2 levels may
not have lasting adverse effects on uterine receptivity
or the adverse effects on the endometrium may be
reversible by coasting. Coasting can be considered as
another option for those patients with serum E2 levels
≥ 5,000 pg/mL [40].
In conclusion, our results and those of other inves-
tigators clearly show that there is still no consensus con-
cerning any adverse role of elevated peri-implantation
E2 levels on IVF outcome. We believe, however, that
there is a threshold peak E2 level above which preg-
nancy and implantation rates are decreased, but this
threshold is likely to be 5,000 pg/mL from our results
and other publications [17,21] rather than 2,500 or
3,000 pg/mL as previously reported. The impairment in
implantation was likely to be related to an adverse
environment in the endometrium. Further studies are
needed to define the optimum E2 range associated
with best IVF-ET outcome.
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